Matches in Nanopublications for { ?s ?p "DDI between Verapamil and Halofantrine - Verapamil, a moderate CYP3A4 inhibitor, may increase the serum concentration of Halofantrine by decreasing its metabolism. Extreme caution with increased cardiac status monitoring should be used during concomitant therapy. [drugbank_resource:DB00661_DB01218]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00661_DB01218 label "DDI between Verapamil and Halofantrine - Verapamil, a moderate CYP3A4 inhibitor, may increase the serum concentration of Halofantrine by decreasing its metabolism. Extreme caution with increased cardiac status monitoring should be used during concomitant therapy. [drugbank_resource:DB00661_DB01218]" assertion.